21172 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA Virus
Sub-classes:UNIVERSAL T CELL-BASED, CMV-VECTORED VACCINE FOR INFLUENZA
#2NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF
#3MODIFIED INFLUENZA VIRUSES
#4METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#5REPLICATION-DEFECTIVE ARENAVIRUS VECTORS
#6TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
#7Method for Obtaining SARS-CoV-2 Aerosol Variants for Oral Vaccines Inducing Gut-based Immunity Against COVID-19
#8Human Cytomegalovirus Immunogenic Composition
#9REPLICATION-COMPETENT CONTROLLED ALPHA-HERPESVIRUS VECTORS AND USES THEREFORE
#10NOVEL USAGE OF ONCOLYTIC GENE-MODIFIED MEASLES VIRUS
#11VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#12CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS
#13PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS
#14INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF
#15SMALLPOX VACCINE FOR CANCER TREATMENT
#16Influenza virus hemagglutinin proteins and uses thereof
#17EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 4a
#18VIRUS AND ANTIGEN PURIFICATION AND CONJUGATION
#19MODIFIED PIV5 VACCINE VECTORS: METHODS OF MAKING AND USES
#20COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE
#21BACTERIAL DELIVERY VEHICLE, PROCESS OF PRODUCTION AND USES THEREOF
#22CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS
#23Vaccine for use in the prophylaxis and/or treatment of a disease
#24MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE
#25NOVEL THI-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS AND USE OF SAME
#26Herpes 2 Antibody System
#27IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#28Methods of predicting ancestral virus sequences and uses thereof
#29Immunogenic Antigens
#30A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#31MICRO DOSING OF VIRAL VACCINES
#32Smallpox vaccine for cancer treatment
#33Methods of vaccine administration
#34MODIFIED ADENOVIRUSES FOR INFECTIOUS DISEASE VACCINE DEVELOPMENT
#35Virus and antigen purification and conjugation
#36NOVEL VERO CELL LINE THAT CAN BE SUSPENSION-CULTURED IN SERUM-FREE MEDIUM, PREPARATION METHOD THEREFOR, AND METHOD FOR PREPARING VIRUSES FOR VACCINES BY USING NOVEL CELL LINE
#37Vaccine for use in the prophylaxis and/or treatment of a disease
#38Mumps virus as a potential oncolytic agent
#39Vaccine for use in the prophylaxis and/or treatment of a disease
#40Replication-defective arenavirus vectors
#41COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND PYRIDOPYRIMIDINE DERIVATIVES
#42TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
#43Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same
#44Influenza virus hemagglutinin proteins and uses thereof
#45Porcine Reproductive and Respiratory Syndrome vaccine virus
#46SMALLPOX VACCINE AND STEM CELLS FOR TREATMENT OF DISEASE
#47USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID TUMORS
#48COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME
#49VIRAL FORMULATIONS CONTAINING AMINO ACIDS
#50Vaccinia virus mutants useful for cancer immunotherapy
#51METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES
#52Recombinant influenza viruses and constructs and uses thereof
#53Conformationally stabilized RSV pre-fusion F proteins
#54Heat-resistant H1N1 subtype influenza virus mutant strain, preparation method and application thereof
#55Anti-coronavirus vaccines
#56Mucosal adjuvant
#57Mutations that confer genetic stability to additional genes in influenza viruses
#58METHODS OF PREDICTING ANCESTRAL VIRUS SEQUENCES AND USES THEREOF
#59Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof
#60CANINE DISTEMPER VACCINES AND METHODS OF TREATMENT USING THE SAME
#61Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
#62Intratumoral Alpha-Emitter Radiation and Activation of Cytoplasmatic Sensors for Intracellular Pathogen
#63PSMA AND STEAP1 VACCINES AND THEIR USES
#64MEASURING ANALYTES IN BIOLOGICAL SAMPLES
#65Therapeutic mitigation of epithelial infection
#66SYNTHETIC CHIMERIC VACCINIA VIRUS
#67Method for acclimating and suspending Vero and second order production process for virus
#68HIV vaccine formulation
#69Attenuated strains of oncolytic rhabdovirus and uses thereof in tumor treatment
#70Modified adenoviruses for cancer vaccines development
#71Replication-defective arenavirus vectors
#72METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS
#73Smallpox vaccine for cancer treatment
#74METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#75Immunogenic compositions comprising
#76Duck hepatitis A virus type 3 mutant CH-P60-117C and construction thereof
#77VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES
#78Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#79Liquid vaccines of live enveloped viruses
#80Aluminum compounds for use in therapeutics and vaccines
#81COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS
#82Adenovirus vectors and uses thereof
#83Vaccinia virus mutants useful for cancer immunotherapy
#84Composition comprising iscom particles and live micro-organisms
#85Methods of predicting ancestral virus sequences and uses thereof
#86Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
#87Methods of vaccine administration
#88Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
#89METHOD FOR RAPID GENERATION OF AN ATTENUATED RNA VIRUS
#90Mumps virus as a potential oncolytic agent
#91VIRAL FORMULATIONS CONTAINING AMINO ACIDS
#92Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
#93METHODS OF IMPROVING EFFICACY OF ALLERGY VACCINES
#94INFLUENZA VIRUS REASSORTMENT
#95Methods of predicting ancestral virus sequences and uses thereof
#96Treatment of haematological malignancies
#97Virus and antigen purification and conjugation
#98Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#99PHARMACEUTICAL COMPOSITION PREVENTING OR TREATING AN INFLUENZA VIRAL INFECTIOUS DISEASE
#100Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#101INFLUENZA VIRUS REASSORTMENT
#102Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
#103METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS
#104Vaccinia virus vectors related to MVA with extensive genomic symmetries
#105Influenza nanovaccine
#106Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
#107Influenza virus hemagglutinin proteins and uses thereof
#108Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
#109Chimeric west nile/zika viruses and methods of use
#110CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS
#111Stable Production of Lentiviral Vectors
#112Heterologous expression cassette, DNA construct and vaccine composition to immunize against flavivirus and/or other pathogens
#113CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF
#114Heat-resistant protective agent, room-temperature-preserved live classical swine fever vaccine, and preparation method and application thereof
#115Vectors and methods for long-term immune evasion to prolong transplant viability
#116Recombinant vaccinia virus and use thereof
#117Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
#118Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#119Yeast-MUC1 immunotherapeutic compositions and uses thereof
#120HIV vaccine formulation
#121Therapeutic HPV18 vaccines
#122Compositions
#123Compositions and methods of replication deficient adenoviral vectors for vaccine applications
#124Influenza vaccines
#125Combination method for treatment of cancer
#126Vaccine against beta-herpesvirus infection and use thereof
#127Immunogenic compositions comprising
#128Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#129Respiratory syncytial virus having cleavage-resistant G protein and related materials and methods
#130Replication-defective arenavirus vectors
#131Method for Treating Melanoma Using a Herpes Simplex Virus and an Immune Checkpoint Inhibitor
#132Methods of predicting ancestral virus sequences and uses thereof
#133HIGH TITER RECOMBINANT INFLUENZA VIRUSES FOR VACCINES
#134PINBALL HERPES ANTIBODY SYSTEM
#135Means and methods for treating HBV
#136Vector co-expressing vaccine and costimulatory molecules
#137Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#138Composition comprising iscom particles and live micro-organisms
#139Vector co-expressing vaccine and costimulatory molecules
#140High titer recombinant influenza viruses with enhanced replication in vero cells
#141Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#142Smallpox vaccine for cancer treatment
#143PORCINE EPIDEMIC DIARRHEA VIRUS VACCINES AND METHODS OF USE THEREOF
#144Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
#145H3 influenza A virus
#146Recombinant Influenza Viruses for Vaccines and Gene Therapy
#147Bivalent swine influenza virus vaccine
#148FILOVIRUS VECTORS AND PARTICLES PRODUCED THEREFROM
#149Subunit vaccine of porcine pseudorabies virus and preparation method
#150Single-cycle virus for the development of canine influenza vaccines
#151Methods of treating and preventing influenza infections
#152Mutations that confer genetic stability to additional genes in influenza viruses
#153Methods and compositions for eliciting an immune response against hepatitis B virus
#154Reverse genetics systems
#155Heat stable liquid rotavirus vaccine
#156Method for rapid generation of an infectious RNA virus
#157Method for rapid generation of an attenuated RNA virus
#158Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
#159Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
#160Mumps virus as a potential oncolytic agent
#161Method of painting micro vesicles
#162Antigenically matched influenza vaccines
#163Sprayer technology
#164DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES
#165Vectors and methods for long-term immune evasion to prolong transplant viability
#166Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
#167Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#168METHOD OF ALTERING EXPRESSION OF ALTERNATIVE VIRAL GLYCOPROTEIN COMPLEXES
#169Synthetic glucopyranosyl lipid adjuvants
#170Stable production of lentiviral vectors
#171Circovirus sequences associated with piglet weight loss disease (PWD)
#172Therapeutic HPV18 vaccines
#173Cytomegalovirus antigens and uses thereof
#174HIV vaccine formulation
#175Vaccine against infectious bronchitis virus
#176RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOSITIONS THEREFROM
#177Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#178TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same
#179Methods of predicting ancestral virus sequences and uses thereof
#180Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines
#181Prophylactic protection against viral infections, particularly HIV
#182MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#183Yeast-MUC1 immunotherapeutic compositions and uses thereof
#184Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#185Drug target and construct for Japanese encephalitis virus infection
#186Synthetic glucopyranosyl lipid adjuvants
#187VACCINES WITH INTERLEUKIN-17 AS AN ADJUVANT
#188Composite antigenic sequences and vaccines
#189Thermostable spray dried rotavirus vaccine formulation and process thereof
#190Hybrid core feline vaccines
#191Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
#192Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#193SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#194Influenza virus reassortment
#195Compositions and methods for producing dendritic cells
#196Porcine epidemic diarrhea virus vaccines and methods of use thereof
#197Modified adenoviruses for cancer vaccines development
#198Viral inhibitory nucleotide sequences and vaccines
#199Immunogenic composition
#200Methods of predicting ancestral virus sequences and uses thereof
#201Therapeutic HPV18 vaccines
#202Smallpox vaccine for cancer treatment
#203Immunogenic compositions and methods
#204Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#205Immunogenic compositions comprising
#206Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
#207Recombinant rift valley fever (RVF) viruses and methods of use
#208Aluminum compounds for use in therapeutics and vaccines
#209Excipients for stabilising viral particles, polypeptides or biological material
#210Promiscuous HPV16-derived T helper epitopes for immunotherapy
#211Recombinant respiratory syncytial virus G protein fragments
#212PRRSV compositions
#213Bunyaviruses with segmented glycoprotein precursor genes and methods for generating these viruses
#214Method of making a virus using duck embryonic derived stem cell lines
#215Method of microwave vacuum drying spherical-shaped pellets of biological materials
#216Vector co-expressing vaccine and costimulatory molecules
#217Bivalent swine influenza virus vaccine
#218Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#219PAPAYA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES IN CANCER THERAPY
#220Method of obtaining thermostable dried vaccine formulations
#221Influenza nucleoprotein vaccines
#222Methods of predicting ancestral virus sequences and uses thereof
#223Mucosal vaccine composition
#224High titer recombinant influenza viruses for vaccines
#225Method of viral purification
#226Post release modification of viral envelopes
#227COMPOSITIONS AND METHODS FOR DIRECTED IMMUNOGEN EVOLUTION AND USES THEREOF
#228Replication-defective arenavirus vectors
#229Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#230Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
#231Vaccines for diseases caused by viruses of the family of reoviridae
#232Adjuvant compositions and related methods
#233Recombinant influenza viruses for vaccines and gene therapy
#234Compositions comprising iscom particles and live micro-organisms
#235Aluminum compounds for use in therapeutics and vaccines
#236Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#237THERMOSENSITIVE MUTANTS OF INFLUENZA VIRUSES
#238Korean-type porcine reproductive and respiratory syndrome (PRRS) virus
#239Porcine reproductive and respiratory syndrome virus compositions and uses thereof
#240H3 influenza a virus
#241METHODS OF PRODUCING INFLUENZA VACCINE COMPOSITIONS
#242Formulations
#243Methods of treating neurodegenerative conditions
#244High titer recombinant influenza viruses with enhanced replication in vero cells
#245Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus
#246Production methods
#247Vaccination strategy
#248Mutations that confer genetic stability to additional genes in influenza viruses
#249Lentiviral vector based immunological compounds against malaria
#250Immunogenic compositions comprising silicified virus and methods of use
#251Influenza virus reassortment
#252SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#253Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#254Methods of Determining Cell Mediated Response
#255VACCINE AGAINST BETA-HERPESVIRUS INFECTION AND USE THEREOF
#256Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
#257Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus
#258Inhalable vaccine compositions and methods
#259Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#260Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#261MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
#262Liquid viral formulations
#263Reverse genetics of negative-strand RNA viruses in yeast
#264Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
#265Vaccine formulations comprising saponin-containing adjuvants
#266Methods of vaccine administration
#267Circovirus sequences associated with piglet weight loss disease (PWD)
#268Circovirus sequences associated with piglet weight loss disease (PWD)
#269VIRAL VACCINE AND PROCESS FOR PREPARING THE SAME
#270PCV2 immunogenic compositions and methods of producing such compositions
#271Recombinant influenza vectors with tandem transcription units
#272REVERSE GENETICS METHODS FOR VIRUS RESCUE
#273Canine respiratory coronavirus for treatment and protection against bacterial infections
#274Influenza virus reassortment method
#275Influenza vaccines
#276Equine encephalitis virus vaccines and methods of using thereof
#277Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
#278Conformationally stabilized RSV pre-fusion F proteins
#279Immunogenic compositions and methods
#280Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#281Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#282Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom
#283H3 influenza A virus
#284ROTAVIRUS PREPARATIONS WITH EXCESS CALCIUM IONS AND HIGH VISCOSITIES THAT ENSURE VIABILITY AT ELEVATED TEMPERATURES
#285Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#286Immunogenic compositions comprising
#287Norovirus immunogens and related materials and methods
#288Synthetic glucopyranosyl lipid adjuvants
#289BROADLY REACTIVE MOSAIC PEPTIDE FOR INFLUENZA VACCINE
#290Lentiviral gene transfer vectors and their medicinal applications
#291Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#292Immunization compositions and methods
#293Reassortant influenza viruses for vaccines
#294Canine coronavirus vaccine
#295Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#296Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications
#297Recombinant influenza viruses and constructs and uses thereof
#298Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
#299Generation of duck cell lines
#300Recombinant rift valley fever (RVF) viruses and methods